Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT03315975
PHASE4
Flu Vaccine Responses in the Setting of Melanoma Treatment
Sponsor: University of Pennsylvania
View on ClinicalTrials.gov
Summary
Influenza vaccination is indicated for all adults, but the immunogenicity of vaccination has not been assessed in all situations. We are conducting a prospective unblinded study of influenza vaccine recipients.
Official title: Influenza Vaccine Responses in the Setting of Melanoma Treatment
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2017-10-20
Completion Date
2026-07-01
Last Updated
2025-08-19
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
Inactivated influenza vaccine
One dose of quadrivalent inactivated influenza vaccine
Locations (1)
University of Pennsylvania
Philadelphia, Pennsylvania, United States